DTYMK and bladder transitional cell carcinoma: The results from these two databases commonly revealed that DTYMK expression was elevated in BLCA, CESC, COAD, glioblastoma multiforme (GBM), head and neck squamous cell carcinoma (HNSC), LIHC, LUAD, LUSC, rectum adenocarcinoma (READ), STAD and UCEC.